Activating variants in PDGFRB result in a spectrum of disorders responsive to imatinib monotherapy
暂无分享，去创建一个
E. Zackai | H. Hakonarson | W. Dobyns | A. Beck | Meredith Wilson | J. Christodoulou | C. Curry | M. Adam | C. Heike | R. Bly | D. Everman | T. Wenger | J. Amiel | J. Perkins | D. Gupta | Dong Li | E. Bhoj | J. Chenbhanich | Julie R. Park | I. Chang | J. Dahl | R. Webster | Natalie L. Wu | Y. Zarate | A. Sun | C. Albert | Shireen S Ganapathi | Danny E. Miller | A. Guimier | M. Boos | Joseph T C Shieh | John P. Dahl